CANNABIS

Dr. Michelle Weiner has been researching medical cannabis for nearly a decade and is considered Florida’s leading expert in medical marijuana for chronic pain. Medical marijuana may be a solution for those suffering from epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Chron’s Disease, Parkinson’s Disease, MS, and other conditions such as Insomnia and Fibromyalgia.

Dr. Michelle Weiner’s team prioritizes personalized botanical medicine and tailors the components and dosages to an individual patient’s needs.


Want to learn more? Schedule a Medical Marijuana Consultation.

How to Get a Medical Marijuana Card in Florida

Why Cannabis? The Endocannabinoid System

Your body makes naturally occurring cannabinoids and is biologically equipped with cannabinoid receptors. This network of receptors found throughout the brain and body, plus our naturally occurring cannabinoids and specific enzymes makes up the ECS. Cannabis consists of more than 400 substances, including 140 cannabinoids such as THC, CBD, CBN, CBG, THCA, terpenes, and flavonoids. Cannabinoids, including CBD and THC, interact with your body’s endocannabinoid system, or ECS. The ECS is a system of receptors found in all mammals. These receptors, CB1 and 2, are located in the brain and nervous system throughout the body. The coolest part? Everyone’s endocannabinoid system is a little different, which is why personalizing the cannabis experience for each user is so important for the most beneficial results.

Take the guesswork out of finding the right CBD or cannabinoid product for you with a DNA test that matches you with the right cannabinoid products for your endocannabinoid system.

RESEARCH & READING

RESEARCH & READING

FEATURED

Cannabis Use and Mindfulness in Young Adults: Preliminary Findings from the Herbal Heart Study Presented at the International Cannabinoid Research Society Scientific Meeting in Spain July, 2024

Dr. Weiner and researchers at the University of Miami investigates associations between mindfulness and quality of life among young adult cannabis users, providing valuable insights into their holistic experiences.


DOWNLOAD THE PDF HERE.

Clinical Endocannabinoid Deficiency Syndrom (CED) - by Dr. Weiner in HighLife

The theory of Clinical Endocannabinoid Deficiency (CED) is based on the concept that many brain disorders are associated with neurotransmitter deficiencies.

READ

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (British Journal of Pharmacology)

Explores the therapeutic potential of cannabis terpenoids - including limonene, myrcene, and caryophyllene - and their synergistic interactions with phytocannabinoids.

READ (PDF)

The Microbiome, Gut-Brain Axis, and Cannabis

This article proposes the theory of clinical endocannabinoid deficiency (CED) to explain common subjective pain conditions like migraine, fibromyalgia, and irritable bowel syndrome.

READ

The COVID-19 cannabis health study: Results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the US

Dr. Weiner and researchers studied how adult medicinal cannabis users with chronic health conditions changed their habits during the COVID-19 pandemic.

READ (PDF)

700 Medical Cannabis Studies, sorted by Disease

Here is a collection of clinical studies, papers and references providing the ultimate resource for medical disorders helped by cannabis.

READ

A Retrospective Medical Record Review of Adults with Non-Cancer Diagnoses Prescribed Medicinal Cannabis

The findings of this study suggest that a balanced formulation of medicinal cannabis is safe and effective in treating older patients, with treatment-resistant neurological conditions seeing the most benefits.

READ

"The body doesn’t know the difference between an experience and a thought, you can literally change your biology, neuro-circuitry, chemistry, hormones, and genes by simply having an inner experience"

Dr. Joe Dispenza